- Eli Lilly and Company
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Indianapolis, November 13 (ots/PRNewswire) -
- 13.11.2009, 15:11:41
- /
- OTE0006
- Eli Lilly and Company
Duloxetine Significantly Reduced Osteoarthritis Knee Pain in New Study
Indianapolis, U.s.a. and Ingelheim, Germany (ots/PRNewswire) --
- 30.01.2009, 12:07:13
- /
- OTE0013
- Eli Lilly and Company
Global 'Inspired by Diabetes' Creative Expression Competition Deadline Extended Until March 31, 2008
Indianapolis (ots/PRNewswire) -
- 05.02.2008, 22:59:08
- /
- OTE0011
- Eli Lilly and Company
BYETTA(R) Study Showed Sustained Blood Glucose Control Over Three Years in People with Type 2 Diabetes
Chicago (ots/PRNewswire) -
- 25.06.2007, 22:20:38
- /
- OTE0011
- Eli Lilly and Company
Cialis(R) (tadalafil) for Once-a-Day Use Approved for the Treatment of Erectile Dysfunction by European Commission
Indianapolis (ots/PRNewswire) -
- 25.06.2007, 13:42:13
- /
- OTE0003
- Eli Lilly and Company
Lilly and International Diabetes Federation Announce Launch of 'Inspired by Diabetes' Creative Expression Competition
Indianapolis and Brussels, Belgium (ots/PRNewswire) -
- 21.06.2007, 16:58:36
- /
- OTE0006
- Eli Lilly and Company
Eli Lilly and Company and Boehringer Ingelheim Announce Changes to Their Contractual Agreements for Yentreve(R)/AriClaim(R)
Indianapolis, and Ingelheim, Germany (ots/PRNewswire) -
- 15.02.2006, 12:10:39
- /
- OTE0003
Alle Aussendungen
Alle Anhänge
